A BILL 
To authorize the Director of the Centers for Disease Control 
and Prevention to award grants to eligible State, Tribal, 
and territorial public health agencies to develop and ad-
minister a program for digital contact tracing for 
COVID–19, and for other purposes. 
Be it enacted by the Senate and House of Representa-
1
tives of the United States of America in Congress assembled, 
2
SECTION 1. SHORT TITLE. 
3
This Act may be cited as the ‘‘Secure Data and Pri-
4
vacy for Contact Tracing Act of 2021’’. 
5
20:40 Feb 23, 2021
H778
2 
•HR 778 IH
SEC. 2. GRANT PROGRAM FOR DIGITAL CONTACT TRACING 
1
FOR COVID–19. 
2
(a) IN GENERAL.—The Director of the Centers for 
3
Disease Control and Prevention shall award grants to eli-
4
gible State, Tribal, and territorial public health agencies 
5
to— 
6
(1) establish a contact tracing program that im-
7
plements traditional contact tracing protocols with 
8
the assistance of digital contact-tracing technology 
9
to track and prevent the spread of COVID–19; 
10
(2) incorporate digital contact-tracing tech-
11
nology into a contact tracing program that imple-
12
ments traditional contact tracing protocols to track 
13
and prevent the spread of COVID–19; and 
14
(3) expand or maintain an existing program as 
15
described in paragraph (1). 
16
(b) USE OF FUNDS.— 
17
(1) IN GENERAL.—Funds received through a 
18
grant under this section may be used for— 
19
(A) the development, maintenance, or 
20
staffing of digital contact tracing programs; 
21
(B) associated outreach and marketing; or 
22
(C) other activities identified by the State, 
23
Tribal, or territorial public health agency re-
24
ceiving the grant as advancing the effectiveness 
25
20:40 Feb 23, 2021
H778
3 
•HR 778 IH
and reach of digital contact-tracing tech-
1
nologies. 
2
(2) EDUCATION AND OUTREACH.—Of the funds 
3
received by a State, Tribal, or territorial public 
4
health agency through a grant under this section, 
5
the agency may use not more than 10 percent of 
6
such funds to integrate education and outreach re-
7
lated to vaccines for COVID–19 into digital contact- 
8
tracing programs. 
9
(c) FUNDING DISQUALIFICATION.—If a State, Trib-
10
al, or territorial public health agency develops or procures 
11
any digital contact-tracing technology with respect to 
12
COVID–19 that does not meet each of the requirements 
13
listed in subsection (d), such State, Tribal, or territorial 
14
public health agency shall be ineligible to receive or con-
15
tinue to receive— 
16
(1) any funds through a grant under this sec-
17
tion; and 
18
(2) any other Federal funds, including under 
19
the CARES Act (Public Law 116–136), for any dig-
20
ital contact-tracing technology with respect to 
21
COVID–19. 
22
(d) DIGITAL CONTACT-TRACING REQUIREMENTS.— 
23
A State, Tribal, or territorial public health agency may 
24
use a grant under this section for digital contact-tracing 
25
20:40 Feb 23, 2021
H778
4 
•HR 778 IH
technology, as described in subsections (a) and (b), only 
1
if the technology meets each of the following requirements: 
2
(1) The technology shall be voluntary for the 
3
user and provide to the user complete and clear in-
4
formation on the intended use and processing of 
5
data collected by the technology. To be voluntary for 
6
the user, the technology shall meet requirements in-
7
cluding each of the following: 
8
(A) Use of the technology and of contact- 
9
tracing data collected using the technology shall 
10
be predicated on the user’s affirmative express 
11
consent. 
12
(B) Use of the technology shall not be a 
13
condition for the reception of government bene-
14
fits. 
15
(C) Use of the technology shall not be 
16
made a condition of employment or employment 
17
status. 
18
(2) The technology shall limit the collection of 
19
data by the technology to only the data that is nec-
20
essary to meet contact tracing objectives, includ-
21
ing— 
22
(A) the status of any person as an infected 
23
or potentially infected person; and 
24
20:40 Feb 23, 2021
H778
5 
•HR 778 IH
(B) the proximity of a person to someone 
1
who is symptomatic or has tested positive. 
2
(3) The technology— 
3
(A) shall delete or de-identify any contact- 
4
tracing data that is individually identifiable in-
5
formation not later than the date that is 30 
6
days after the end of the COVID–19 emergency 
7
declaration; and 
8
(B) shall include notifications to prompt 
9
users to disable or completely remove any dig-
10
ital contact-tracing technology where practical. 
11
(4) The technology shall have robust contact 
12
detection specifications, including for distance and 
13
time, that allow for detection consistent with guid-
14
ance of the Centers for Disease Control and Preven-
15
tion on COVID–19. 
16
(5) The technology shall ensure that the storing 
17
of proximity and any contact-tracing data is 
18
encrypted to the maximum extent possible. 
19
(e) PLAN FOR INTEROPERABILITY.—As a condition 
20
on receipt of a grant under this section, a State, Tribal, 
21
or territorial public health agency shall— 
22
(1) develop and make publicly available a plan 
23
for how the digital contact-tracing technology of the 
24
agency with respect to COVID–19 augments— 
25
20:40 Feb 23, 2021
H778
6 
•HR 778 IH
(A) traditional contact tracing efforts, if 
1
applicable; and 
2
(B) statewide efforts to prevent, prepare 
3
for, and respond to COVID–19; and 
4
(2) include in such plan a description of the 
5
agency’s efforts to ensure that the digital contact- 
6
tracing technologies of the agency with respect to 
7
COVID–19 are interoperable with the digital con-
8
tact-tracing technology and public health agency 
9
databases of other jurisdictions with respect to 
10
COVID–19; and 
11
(3) ensure that data collected by the digital 
12
contact-tracing technology of the agency— 
13
(A) is accessed and processed only by pub-
14
lic health authorities (or their designees); and 
15
(B) is not shared with any person, or 
16
accessed or used by any person, for any purpose 
17
other than diagnosis, containment, treatment, 
18
or reduction of, or research into, COVID–19. 
19
(f) INDEPENDENT SECURITY ASSESSMENTS.— 
20
(1) IN GENERAL.—As a condition on receipt of 
21
a grant under this section, a State, Tribal, or terri-
22
torial public health agency shall— 
23
(A) establish procedures for completing or 
24
obtaining independent security assessments of 
25
20:40 Feb 23, 2021
H778
7 
•HR 778 IH
digital contact tracing infrastructure to ensure 
1
that physical and network security is resilient 
2
and secure; and 
3
(B) develop a process to address the miti-
4
gation 
or 
remediation 
of 
the 
security 
5
vulnerabilities discovered during such inde-
6
pendent security assessments. 
7
(2) SOURCE CODE.—A State, Tribal, or terri-
8
torial public health agency should consider making 
9
public the source code of the digital contact-tracing 
10
technology used by the agency. 
11
(g) APPLICATION.—To seek a grant under this sec-
12
tion, an eligible State, Tribal, or territorial public health 
13
agency shall submit an application in such form, in such 
14
manner, and containing such information and assurances 
15
as the Director may require. 
16
(h) SECURING DIGITAL CONTACT-TRACING DATA.— 
17
(1) IN
GENERAL.—The provisions of the 
18
HIPAA privacy and security law (as defined in sec-
19
tion 3009(a)(2) of the Public Health Service Act (42 
20
U.S.C. 300jj–19(a)(2))) shall apply to a State, Trib-
21
al, or territorial public health agency receiving a 
22
grant under subsection (a) with respect to individ-
23
ually identifiable health information (as defined in 
24
section 1171(a)(6) of the Social Security Act (42 
25
20:40 Feb 23, 2021
H778
8 
•HR 778 IH
U.S.C. 1320d(a)(6))) received by, maintained on, or 
1
transmitted through a contact tracing program de-
2
scribed in such subsection (a) in the same manner 
3
as such provisions apply with respect to such infor-
4
mation and a covered entity (as defined in section 
5
13400(3) 
of 
the 
HITECH 
Act 
(42 
U.S.C. 
6
17921(3))). 
7
(2) BUSINESS ASSOCIATES.— 
8
(A) IN GENERAL.—Any entity with a con-
9
tract in effect with an agency described in para-
10
graph (1) for the development, maintenance, or 
11
operation of a program described in such para-
12
graph shall be deemed to be a business asso-
13
ciate of such agency for purposes of subtitle D 
14
of the HITECH Act (42 U.S.C. 17921 et seq.). 
15
(B) REVISION OF SAMPLE AGREEMENT.— 
16
Not later than 180 days after the date of the 
17
enactment of this Act, the Secretary of Health 
18
and Human Services shall revise the sample 
19
business associate agreement provisions pub-
20
lished on January 25, 2013, to take account of 
21
the provisions of this subsection. 
22
(C) EFFECTIVE DATE.—The provisions of 
23
subparagraph (A) shall apply beginning on the 
24
day after the Secretary of Health and Human 
25
20:40 Feb 23, 2021
H778
9 
•HR 778 IH
Services revises the provisions described in sub-
1
paragraph (B). 
2
(i) LIMITATION ON USE OF DATA.—Data generated 
3
in connection with the operation of digital contact-tracing 
4
technology funded pursuant to this section may not be 
5
used for any punitive purpose, including law enforcement, 
6
immigration enforcement, or criminal prosecution. Such 
7
data and any information derived from it, whether in 
8
whole or in part, may not be received as evidence in any 
9
trial, hearing, or other proceeding in or before any court, 
10
grand jury, department, officer, agency, regulatory body, 
11
legislative committee, or other authority of the United 
12
States, a State, or a political subdivision thereof. 
13
(j) REPORT
TO CONGRESS.—Not later than 24 
14
months after the date of enactment of this Act, the Comp-
15
troller General of the United States shall— 
16
(1) evaluate the outcome of the grants awarded 
17
under this section, including an assessment of the 
18
impact of the implementation of digital contact trac-
19
ing programs funded through such grants on the 
20
spread of COVID–19; and 
21
(2) submit to the Congress a report on the re-
22
sults of such evaluation. 
23
(k) DEFINITIONS.—In this section: 
24
20:40 Feb 23, 2021
H778
10 
•HR 778 IH
(1) AFFIRMATIVE
EXPRESS
CONSENT.—The 
1
term ‘‘affirmative express consent’’ means an affirm-
2
ative act by an individual that clearly and conspicu-
3
ously communicates the individual’s authorization 
4
for an act or practice, in response to a specific re-
5
quest that— 
6
(A) is provided to the individual in a clear 
7
and conspicuous disclosure that is separate 
8
from other options or acceptance of general 
9
terms; 
10
(B) includes a description of each act or 
11
practice for which the individual’s consent is 
12
sought and— 
13
(i) is written clearly and unmistakably 
14
stated; and 
15
(ii) includes a prominent heading that 
16
would enable a reasonable individual to 
17
identify and understand the act or prac-
18
tice; and 
19
(C) cannot be inferred from inaction. 
20
(2) CONTACT-TRACING DATA.—The term ‘‘con-
21
tact-tracing data’’ means information linked or rea-
22
sonably linkable to a user or device, that— 
23
(A) concerns the COVID–19 pandemic; 
24
and 
25
20:40 Feb 23, 2021
H778
11 
•HR 778 IH
(B) is gathered, processed, or transferred 
1
by digital contact-tracing technology. 
2
(3) COVID–19 EMERGENCY
DECLARATION.— 
3
The term ‘‘COVID–19 emergency declaration’’ has 
4
the meaning given to such term in section 
5
1135(g)(1)(B) of the Social Security Act (42 U.S.C. 
6
1320b–5). 
7
(4) DE-IDENTIFY.—The term ‘‘de-identify’’ 
8
means to ensure that information cannot reasonably 
9
identify, relate to, describe, be capable of being asso-
10
ciated with, or be linked, directly or indirectly, to a 
11
particular individual. 
12
(5) DESIGNEE.—The term ‘‘designee’’— 
13
(A) subject to subparagraph (B), means 
14
any person or entity, other than a public health 
15
agency, that collects, processes, or transfers 
16
contact-tracing data in the course of performing 
17
a service or function on behalf of, for the ben-
18
efit of, under instruction of, and under contrac-
19
tual agreement with a public health authority; 
20
and 
21
(B) excludes any Federal, State, Tribal, 
22
territorial, or local law (including immigration 
23
law) enforcement personnel or entity. 
24
20:40 Feb 23, 2021
H778
12 
•HR 778 IH
(6) 
DIGITAL
CONTACT-TRACING
TECH-
1
NOLOGY.— 
2
(A) IN GENERAL.—The term ‘‘digital con-
3
tact-tracing technology’’ means a website, on-
4
line application, mobile application, mobile oper-
5
ating system feature, or smart device applica-
6
tion that is designed, in part or in full, for the 
7
purpose of— 
8
(i) determining that a contact incident 
9
has occurred relating to the COVID–19 
10
pandemic; and 
11
(ii) taking consequent steps such as 
12
reporting the incident to a public health 
13
authority or user, or providing guidance or 
14
instructions to the user of the mobile de-
15
vice or the user’s household. 
16
(B) LIMITATIONS.—Such term does not in-
17
clude any technology to assist individuals to 
18
evaluate whether they are experiencing COVID– 
19
19 symptoms to the extent the technology is not 
20
used as described in subparagraph (A). 
21
(7) DIRECTOR.—The term ‘‘Director’’ means 
22
the Director of the Centers for Disease Control and 
23
Prevention. 
24
20:40 Feb 23, 2021
H778
13 
•HR 778 IH
(8) MOBILE APPLICATION.—The term ‘‘mobile 
1
application’’ means a software program that runs on 
2
the operating system of a mobile device. 
3
(9) MOBILE
DEVICE.—The term ‘‘mobile de-
4
vice’’ means a smartphone, tablet computer, or simi-
5
lar portable computing device that transmits data 
6
over a wireless connection. 
7
(10) SOURCE CODE.—The term ‘‘source code’’ 
8
is the programming instruction for a computer pro-
9
gram in its original form and saved in a file. 
10
(11) TRADITIONAL
CONTACT
TRACING.—The 
11
term ‘‘traditional contact tracing’’ means contact 
12
tracing by traditional means prior to contemporary 
13
digital contact tracing. 
14
(12) USER.—The term ‘‘user’’ means a member 
15
of the public who utilizes the software or hardware 
16
product. 
17
(l) AUTHORIZATION OF APPROPRIATIONS.—To carry 
18
out this section, there are authorized to be appropriated 
19
$75,000,000, to remain available until expended. 
20
Æ 
20:40 Feb 23, 2021
H778
